Mounjaro 5 mg/0.5 ml (Tirzepatide) Vial with 1 Ampoule Skip to content
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping to all of Mexico.
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping throughout Mexico

Mounjaro 5 mg/0.5 ml (Tirzepatide) Vial with 1 Ampoule

by Lilly
Sold out
Original price $ 2,242.00
Original price $ 2,242.00 - Original price $ 2,242.00
Original price $ 2,242.00
Current price $ 2,017.80
$ 2,017.80 - $ 2,017.80
Current price $ 2,017.80

La venta de este medicamento requiere receta médica. Su dispensación está sujeta a la validación de la receta y al cumplimiento de la normativa sanitaria vigente. La información contenida en este sitio tiene fines exclusivamente informativos y comerciales, incluyendo la descripción y el precio del producto, y no sustituye la valoración, diagnóstico o prescripción de un profesional de la salud.

SKU 7501082243642
Availability:
Out of stock
Notify me when they have inventory available

¿Necesitas este producto u otro medicamento?

Este producto está agotado por el momento. Nuestros asesores farmacéuticos pueden ayudarte a conseguirlo o encontrar la mejor alternativa para tu tratamiento.

Contáctanos por WhatsApp

Category

Medication

Line

Antidiabetic

Brand

Mounjaro

Molecule

Tirzepatide

Presentation

5 mg / 0.5 ml vial

Laboratory

Lilly

Indications

Mounjaro (Tirzepatide) is indicated as a treatment for adults with type 2 diabetes mellitus, in combination with diet and exercise to improve glycemic control. This medication acts as a GLP-1 and GIP receptor agonist, which helps to increase insulin secretion in response to hyperglycemia and to decrease hepatic glucose production. In addition, Mounjaro has been observed to contribute to weight reduction in overweight or obese patients with type 2 diabetes.

Composition

Each Mounjaro vial contains: 5 mg of tirzepatide as active ingredient and excipients necessary for the formulation.

Contraindications

This medication is contraindicated in patients with known hypersensitivity to tirzepatide or any of the excipients. It should not be used in patients with a history of acute pancreatitis or in those with type 1 diabetes.

Precautions

Caution should be exercised in patients with a history of pancreatic disease, as well as in those with compromised renal or hepatic function. It is important to monitor patients' blood glucose and regularly follow up on their condition. The use of Mounjaro may increase the risk of hypoglycemia, especially if used in combination with other medications that also lower blood glucose.

Storage

Store in refrigeration between 2 °C and 8 °C. Do not freeze. Keep the medication out of reach of children and protect it from light.

Prescription required for sale.

Consult your doctor.

Shipping

  1. Free home delivery by local branches on orders over $1000. Otherwise, a $50 fee will be added in the cities of Querétaro and La Paz, BCS, and $150 in San José del Cabo and Cabo San Lucas, BCS.
  2. FREE national shipping via ground on orders over $1,500.00. Otherwise, a fee of $170.00 MXN (One hundred seventy Mexican pesos) will be added for a standard package with dimensions up to 20cm x 20cm x 20cm and 1kg in weight, and $290.00 MXN (Two hundred ninety Mexican pesos) for packages exceeding the aforementioned dimensions or weight.
  3. In case of oversized items, the corresponding fee will apply according to the parcel service.
  4. Orders received after 2:00 PM will be shipped the next day.
  5. For more details, please consult our shipping policy.

Payment and Security

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Category

Medication

Line

Antidiabetic

Brand

Mounjaro

Molecule

Tirzepatide

Presentation

5 mg / 0.5 ml vial

Laboratory

Lilly

Indications

Mounjaro (Tirzepatide) is indicated as a treatment for adults with type 2 diabetes mellitus, in combination with diet and exercise to improve glycemic control. This medication acts as a GLP-1 and GIP receptor agonist, which helps to increase insulin secretion in response to hyperglycemia and to decrease hepatic glucose production. In addition, Mounjaro has been observed to contribute to weight reduction in overweight or obese patients with type 2 diabetes.

Composition

Each Mounjaro vial contains: 5 mg of tirzepatide as active ingredient and excipients necessary for the formulation.

Contraindications

This medication is contraindicated in patients with known hypersensitivity to tirzepatide or any of the excipients. It should not be used in patients with a history of acute pancreatitis or in those with type 1 diabetes.

Precautions

Caution should be exercised in patients with a history of pancreatic disease, as well as in those with compromised renal or hepatic function. It is important to monitor patients' blood glucose and regularly follow up on their condition. The use of Mounjaro may increase the risk of hypoglycemia, especially if used in combination with other medications that also lower blood glucose.

Storage

Store in refrigeration between 2 °C and 8 °C. Do not freeze. Keep the medication out of reach of children and protect it from light.

Prescription required for sale.

Consult your doctor.